Business · 21/05/2025Updated: 10/17/2026 · 1 min read
FDA Revokes Emergency Use Authorizations for COVID-19 Treatments
Summary
The FDA has revoked emergency use authorizations for Fresenius Medical Care North America's multiFiltrate PRO System and Baxter Healthcare Corp.'s REGIOCIT, citing the end of the COVID-19 pandemic.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →